DALLAS — Presented results found high rates of postoperative venous thromboembolism and low rates of prophylaxis prescriptions in patients who underwent orthopedic surgery for metastatic bone disease of the long bones or pelvis.
“Patients with advanced cancer are known to be hypercoagulable due to alterations in the normal coagulation cascade. In addition to that, many of the chemotherapy agents that we use to treat disease can also make patients hypercoagulable,” Annalise G. Abbott, MD, said in her presentation at the Orthopaedic Research Society Annual Meeting. “Despite